-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Candel Therapeutics (NASDAQ:CADL) Given “Buy” Rating at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Candel Therapeutics (NASDAQ:CADL – Free Report) in a report published on Wednesday morning,Benzinga reports. They currently have a $19.00 target price on the stock. HC Wainwright also issued estimates for Candel Therapeutics’ FY2025 earnings at ($1.39) EPS. A number of other research firms have also weighed […]
HC Wainwright reaffirmed their buy rating on shares of Candel Therapeutics (NASDAQ:CADL – Free Report) in a report published on Wednesday morning,Benzinga reports. They currently have a $19.00 target price on the stock. HC Wainwright also issued estimates for Candel Therapeutics’ FY2025 earnings at ($1.39) EPS. A number of other research firms have also weighed […]
